ClinicalTrials.Veeva

Menu

Evaluation of Integrating MIYCN Interventions in Existing CGPP of PCI

F

FHI 360

Status

Completed

Conditions

Polio

Treatments

Other: Capacity Building
Other: Exclusive Breast Feeding
Other: Maternal dietary diversity
Other: Community mobilization
Other: Diet diversity in complementary feeding
Other: Use of existing platforms VHSND
Other: Strategic use of data

Study type

Interventional

Funder types

Other

Identifiers

NCT03368885
1101870

Details and patient eligibility

About

The study has two arms; both experimental and control areas will receive standard interventions given under polio eradication program of PCI. Participants in the experimental arm receive additional interventions on nutrition (improve diet diversity in pregnant women and children of 6-23 months) for exact 12 months. The study includes awareness generation (regarding nutrition) through community mobilization, counseling and capacity building of community mobilization.

Full description

The experimental arm will receive the following interventions:

  1. Interpersonal communication (IPC) to reach target women (Women in their 2nd or 3rd trimester of pregnancy and women with 6-23 months old child) to deliver messages on maternal nutrition package and complementary feeding through home visits made by Community Mobilization Coordinator (CMC).
  2. Expanded community mobilization involving key influencers in family like husbands and mothers -in-law and community opinion leaders, religious leaders, Village Health Sanitation and Nutrition Committee (VHSNC) members. The aims are to improve awareness, shift norms and perceptions, engage husbands and local opinion leaders to promote healthy behaviour practices related to maternal nutrition and complementary feeding.
  3. Strategic use of data to design a context-specific program and track the progress of the program with regards to impact on social norms and behaviors at household/community level and demonstrate the feasibility of integrating select MIYCN interventions in polio eradication platforms.
  4. Convergence: The convergence will mainly focus on three Cs - maintain consistency, avoid conflict and enhance cooperation. This will aid in passing consistent MIYCN messages to the target community and ensure effective teamwork, collaboration and mutual support

Enrollment

2,590 patients

Sex

Female

Ages

15 to 49 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

For Community

  • • Women aged 15-49 years

    • Willing and able to provide consent
    • Women in 2nd and 3rd trimester of pregnancy and / or
    • Women with children aged 6-23 months For CMC
    • Women aged 18+
    • Currently appointed a CMC in a selected HRA
    • Willing and able to provide consent

Exclusion criteria

  • Women in first trimester of pregnancy
  • Women whose index child (youngest child, between 6-23 months of age) is not her biological child
  • Women whose index child is not currently living with the mother

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

2,590 participants in 2 patient groups

Experimental area PCI
Experimental group
Description:
In this arm, in addition to the standard care for Polio eradication program activities of CGPP project, the following interventions are added: Maternal dietary diversity; Diet diversity in complementary feeding; Exclusive breast feeding; Community mobilization; Capacity building; Convergence;Use of existing platforms VHSND; Strategic Use of Data
Treatment:
Other: Strategic use of data
Other: Use of existing platforms VHSND
Other: Diet diversity in complementary feeding
Other: Maternal dietary diversity
Other: Capacity Building
Other: Community mobilization
Other: Exclusive Breast Feeding
Control area PCI
No Intervention group
Description:
This arm will receive standard care with respect to Polio eradication program activities of CGPP such as awareness generation around Polio and routine immunization, hand washing and sanitation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems